Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors
Diseases of the Digestive System - Esophagus | Diseases of the Digestive System - Small Intestines, Large Intestines & Rectum | Diseases of the Digestive System - Stomach
What is the purpose of this trial?
The objective of this study is to evaluate the safety and efficacy of IW-3718 administered to patients with GERD who continue to have persistent symptoms, such as heartburn and regurgitation, while receiving once-daily (QD), standarddose proton pump inhibitors (PPIs).
- Ages18 years and older
- Trial withIronwood Pharmaceuticals, Inc.
- Start Date07/01/2019
- End Date12/31/2019
- Last Updated07/24/2019
- Study HIC#2000023752